Hypertrophy

Citations 151-160 of 683 total displayed.

Past content (since Mar 1999):

Scientific Contributions
Gender Differences in Left Ventricular Structure and Function During Antihypertensive Treatment. The Losartan Intervention for Endpoint Reduction in Hypertension Study: Eva Gerdts, Peter M. Okin, Giovanni de Simone, Dana Cramariuc, Kristian Wachtell, Kurt Boman, and Richard B. Devereux
Hypertension published February 7, 2008, doi:10.1161/HYPERTENSIONAHA.107.107474 [Abstract]

Scientific Contributions
Low-Intensity Exercise Training Delays Heart Failure and Improves Survival in Female Hypertensive Heart Failure Rats: Adam J. Chicco, Sylvia A. McCune, Craig A. Emter, Genevieve C. Sparagna, Meredith L. Rees, David A. Bolden, Kurt D. Marshall, Robert C. Murphy, and Russell L. Moore
Hypertension published February 7, 2008, doi:10.1161/HYPERTENSIONAHA.107.107078 [Abstract]

Scientific Contributions
Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy. Results From the Losartan Intervention For Endpoint Reduction in Hypertension Study: Ingrid Os, Veronica Franco, Sverre E. Kjeldsen, Karin Manhem, Richard B. Devereux, Eva Gerdts, Darcy A. Hille, Paulette A. Lyle, Peter M. Okin, Björn Dahlöf, and Suzanne Oparil
Hypertension published February 7, 2008, doi:10.1161/HYPERTENSIONAHA.107.105296 [Abstract]

Letters to the Editor
Association of Increased Plasma Cardiotrophin-1 With Left Ventricular Mass Indexes in Normotensive Morbid Obesity: Alexis Elias Malavazos, Federica Ermetici, Lelio Morricone, Alessandra Delnevo, Calin Coman, Bruno Ambrosi, and Massimiliano Marco Corsi
Hypertension 2008;51:e8; published online before print as doi:10.1161/HYPERTENSIONAHA.107.105346 [Full text]

Letters to the Editor
Response to Association of Increased Plasma Cardiotrophin-1 With Left Ventricular Mass Indexes in Normotensive Morbid Obesity: Begoña López, Cristina Natal, Nerea Varo, José M. Castellano, Joaquín Barba, and Javier Díez
Hypertension 2008;51:e10; published online before print as doi:10.1161/HYPERTENSIONAHA.107.105890 [Full text]

Editorial Commentaries
Assessing Left Ventricular Performance: A Rashomon Effect: Giovanni de Simone and Richard B. Devereux
Hypertension 2008;51:179-181; published online before print as doi:10.1161/HYPERTENSIONAHA.107.100222 [Full text]

Original Articles
Novel Role of Protein Kinase C- ${delta}$ Tyr³¹¹ Phosphorylation in Vascular Smooth Muscle Cell Hypertrophy by Angiotensin II: Hidekatsu Nakashima, Gerald D. Frank, Heigoro Shirai, Akinari Hinoki, Sadaharu Higuchi, Haruhiko Ohtsu, Kunie Eguchi, Archana Sanjay, Mary E. Reyland, Peter J. Dempsey, Tadashi Inagami, and Satoru Eguchi
Hypertension 2008;51:232-238; published online before print as doi:10.1161/HYPERTENSIONAHA.107.101253 [Abstract] [Full text]

Original Articles
Suppression of Cardiomyocyte Hypertrophy by Inhibition of the Ubiquitin-Proteasome System: Silke Meiners, Henryk Dreger, Mandy Fechner, Sven Bieler, Wim Rother, Christoph Günther, Gert Baumann, Verena Stangl, and Karl Stangl
Hypertension 2008;51:302-308; published online before print as doi:10.1161/HYPERTENSIONAHA.107.097816 [Abstract] [Full text]

Original Articles
Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes: Evidence for a Stretch-Specific Gene Program: Derk Frank, Christian Kuhn, Benedikt Brors, Christiane Hanselmann, Mark Lüdde, Hugo A. Katus, and Norbert Frey
Hypertension 2008;51:309-318; published online before print as doi:10.1161/HYPERTENSIONAHA.107.098046 [Abstract] [Full text]

Original Articles
Urotensin II and Cardiomyopathy in End-Stage Renal Disease: Carmine Zoccali, Francesca Mallamaci, Frank Antonio Benedetto, Giovanni Tripepi, Patrizia Pizzini, Sebastiano Cutrupi, and Lorenzo Malatino
Hypertension 2008;51:326-333; published online before print as doi:10.1161/HYPERTENSIONAHA.107.101188 [Abstract] [Full text]

Subspecialty Collections Home

Show Hypertrophy
collections from other journals.